1 Melmed S,Casanueva FF,Hoffman AR,et al.Diagnosis and treatment of hyperprolactinemia:an Endocrine Society clinical practice guideline.J Clin Endocrinology Metabolism,2011,96:273-288. 2 Olesen JB,Lip GYH,Kamper AL,et al.Stroke and bleeding in atrial fibrillation with chronic kidney disease.New Eng J Med,2012,367:625-635. 3 叶任高.临床肾脏病学.第2版.北京:人民卫生出版社,2007:174. 4 乐杰.妇产科学.北京:人民卫生出版社,2007:360-382. 5 Glezer A,Bronstein MD.Approach to the patient with persistent hyperprolactinemia and negative sellar imaging.J Clin Endocrinol Metabolism,2012,97:2211-2216. 6 Cheng HT,Huang JW,Chiang CK,et al.Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.J Clin Endocrinology Metabolism,2012,97:1268-1276. 7 Meuwese CL,Carrero JJ.Chronic Kidney Disease and Hypothalamic-Pituitary Axis Dysfunction:The Chicken or the Egg? Arch Med Res,2013,44:591-600. 8 Kutovaja I,Bhatia K.Clinical aspects of endocrinology:parathyroid and adrenal gland disorders.Anaesthesia Int Care Med,2014,15:441-445. 9 Van-Pottelbergh G,Bartholomeeusen S,Buntinx F,et al.The prevalence of chronic kidney disease in a Flemish primary care morbidity register.Age and ageing,2012,41:231-233. 10 Hladunewich M,Hercz AE,Keunen J,et al.Pregnancy in end stage renal disease//Seminars in dialysis.Blackwell Publishing Ltd,2011,24:634-639. (